NCT00624000View on ClinicalTrials.gov

IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion

NACompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

December 31, 2008

Conditions

Ischemic Stroke

Interventions

DRUG

IV tpa (Alteplase) vs IA tpa (Alteplase)

Alteplase was administered Either IA or IV x 1

Trial Locations (1)

27599-7025

University of North Carolina Stroke Center, Chapel Hill

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER